Optimization of R&D Tax Credits (SR&ED) for Pharmaceutical, Biotechnology, and Nutraceutical Companies
Organizations operating in the pharmaceutical, biotechnology, and nutraceutical sectors invest heavily in research and development to advance scientific knowledge, meet regulatory requirements, and bring innovative products to market. These activities often involve significant technical uncertainty, rigorous experimentation, and high development costs. The Scientific Research and Experimental Development (SR&ED) tax credit program is designed to support precisely this type of innovation.
SR&ED Eligibility for Life Sciences and Regulated R&D
Companies may qualify for federal and provincial SR&ED tax credits when conducting R&D activities aimed at achieving technological advancement in areas such as:
- Drug discovery, formulation, and delivery systems.
- Preclinical and clinical process optimization.
- Cell culture, fermentation, and scale-up methodologies.
- Analytical method development and validation.
- Nutraceutical formulation, bioavailability, and stability studies.
- Bioprocessing and molecular biology research.
- Manufacturing process development under GMP constraints.
Eligibility applies even when R&D is incremental, iterative, or embedded within regulatory-driven development, provided technological uncertainty is present and systematic experimentation is performed.
Specialized SR&ED Consulting for Pharma, Biotech, and Nutraceutical Companies
Pro Gestion specializes in SR&ED tax credit consulting for life sciences organizations, combining scientific insight with financial expertise and deep knowledge of CRA compliance requirements. Our multidisciplinary team understands the unique challenges of regulated R&D environments, including documentation standards, experimental protocols, and commercialization timelines.
We work collaboratively with your scientific, regulatory, and finance teams to:
- Identify qualifying SR&ED activities across discovery, development, and scale-up phases.
- Capture eligible labour, materials, clinical trial support, subcontractor, and overhead costs.
- Translate complex scientific work into clear, defensible technical narratives.
- Strengthen claims to withstand CRA review and audit scrutiny.
- Maximize SR&ED tax credit recovery while minimizing compliance risk.
Transforming Life Sciences R&D into Strategic Capital
Our disciplined approach ensures your R&D investments generate measurable financial returns, supporting cash flow, reinvestment in innovation, and long-term growth. Given the continuous nature of pharmaceutical, biotech, and nutraceutical R&D, Pro Gestion acts as a long-term SR&ED partner, helping you integrate SR&ED best practices into your research planning, documentation, and reporting processes.
Free SR&ED Eligibility Assessment for Life Sciences Companies
Discover how much your pharmaceutical, biotechnology, or nutraceutical R&D may be worth. Contact Pro Gestion today for a free, no-obligation SR&ED eligibility assessment and learn how our proven SR&ED tax credit services can help you maximize incentives, ensure CRA compliance, and retain critical capital to accelerate scientific innovation.